These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 216115)

  • 1. Recent studies on the role of the immune response in resistance to virus-induced leukemias and lymphomas.
    Meruelo D; McDevitt HO
    Semin Hematol; 1978 Oct; 15(4):399-419. PubMed ID: 216115
    [No Abstract]   [Full Text] [Related]  

  • 2. Effect of non-H-2-linked genes on anti-virus immune responses and long-term survival in mice persistently infected with E-55+ murine leukemia virus.
    Avidan N; Tumas-Brundage KM; Sieck TG; Prystowsky MB; Blank KJ
    Virology; 1995 Aug; 211(2):507-15. PubMed ID: 7645254
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Each T-cell lymphoma induced by a particular murine leukemia virus bears surface receptors specific for that virus.
    McGrath M; Weissman IL; Baird S; Raschke W; Decleve A; Lieberman M; Kaplan HS
    Birth Defects Orig Artic Ser; 1978; 14(2):349-61. PubMed ID: 76488
    [No Abstract]   [Full Text] [Related]  

  • 4. Susceptibility and resistance to Moloney murine leukemia virus-induced promonocytic leukemia.
    Nazarov V; Hilbert D; Wolff L
    Virology; 1994 Dec; 205(2):479-85. PubMed ID: 7975249
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A crucial role of the H-2 D locus in the regulation of both the D- and the K-associated cytotoxic T lymphocyte response against Moloney leukemia virus, demonstrated with two Db mutants.
    Stukart MJ; Vos A; Boes J; Melvold RW; Bailey DW; Melief CJ
    J Immunol; 1982 Mar; 128(3):1360-4. PubMed ID: 6799575
    [No Abstract]   [Full Text] [Related]  

  • 6. Genetic control of the induction of cytolytic T lymphocyte responses to AKR/Gross viral leukemias. I. H-2-encoded dominant gene control.
    Green WR
    J Immunol; 1984 May; 132(5):2658-64. PubMed ID: 6425409
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Incidence and phenotypic heterogeneity of Moloney virus-induced leukemias: a multigenic control.
    Debre P; Gisselbrecht S; Boyer B; Levy JP
    Blood Cells; 1981; 7(2):301-11. PubMed ID: 6975141
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulation of H-2 class I gene expression in virally transformed and infected cells.
    Brown GD; Choi Y; Pampeno C; Meruelo D
    Crit Rev Immunol; 1988; 8(3):175-215. PubMed ID: 3280242
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Genetic control of murine leukemias induced by Moloney virus].
    Debré P; Gisselbrecht S; Boyer B; Lévy JP
    Bull Cancer; 1982; 69(2):178-87. PubMed ID: 6812667
    [No Abstract]   [Full Text] [Related]  

  • 10. Host genetic factors that control immune responses to retrovirus infections.
    Miyazawa M; Tsuji-Kawahara S; Kanari Y
    Vaccine; 2008 Jun; 26(24):2981-96. PubMed ID: 18255203
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Major histocompatibility complex class II-regulated immunity to murine leukemia virus protects against early T- but not late B-cell lymphomas.
    Vasmel WL; Zijlstra M; Radaszkiewicz T; Leupers CJ; de Goede RE; Melief CJ
    J Virol; 1988 Sep; 62(9):3156-66. PubMed ID: 2841468
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro studies of cell-mediated immunity to Moloney murine leukemia virus and Moloney leukemia-associated surface antigens.
    Ng AK; Ames RS; McIntire RK; Herberman RB
    Cancer Res; 1979 Dec; 39(12):4887-93. PubMed ID: 387218
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic control of the induction of cytolytic T lymphocyte responses to AKR/Gross viral leukemias. II. Negative control by the Fv-1 locus in AKR mice of responder H-2b haplotype.
    Green WR
    J Immunol; 1984 May; 132(5):2665-71. PubMed ID: 6425410
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The immunogenicity of experimental tumors is strongly biased by the expression of dominant viral cytotoxic T-lymphocyte epitopes.
    Iezzi G; Rivolta L; Ronchetti A; Martin-Fontecha A; Rosato A; Protti MP; Sabbadini MG; Bellone M
    Cancer Res; 1997 Jul; 57(13):2564-8. PubMed ID: 9205054
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differences in the immune response during the acute phase of E-55+ murine leukemia virus infection in progressor BALB and long term nonprogressor C57BL mice.
    Panoutsakopoulou V; Little CS; Sieck TG; Blankenhorn EP; Blank KJ
    J Immunol; 1998 Jul; 161(1):17-26. PubMed ID: 9647202
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Virus-specific T cell response prevents lymphoma development in mice infected by intrathymic inoculation of Moloney leukaemia virus (M-MuLV).
    Zanovello P; Collavo D; Ronchese F; De Rossi A; Biasi G; Chieco-Bianchi L
    Immunology; 1984 Jan; 51(1):9-16. PubMed ID: 6228521
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential antigen presentation in tumor immunity.
    Schatten S; Drebin JA; Granstein RD; Greene MI
    Fed Proc; 1984 Jun; 43(9):2460-4. PubMed ID: 6327399
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Experimental models and conceptual approaches to studies of lymphomas and leukemia: etiology, biology, and control.
    Ihle JN
    Semin Hematol; 1978 Apr; 15(2):95-115. PubMed ID: 206975
    [No Abstract]   [Full Text] [Related]  

  • 19. Receptors for immunoglobulin and complement on mouse leukemias and lymphomas.
    Shevach E; Herberman R; Lieberman R; Frank MM; Green I
    J Immunol; 1972 Feb; 108(2):325-8. PubMed ID: 4340285
    [No Abstract]   [Full Text] [Related]  

  • 20. Variants from a MLV-induced lymphoma selected for decreased sensitivity to NK lysis.
    Grönberg A; Kiessling R; Eriksson E; Hansson M
    J Immunol; 1981 Nov; 127(5):1734-9. PubMed ID: 6975295
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.